Pasithea Therapeutics Corp. Balance Sheet
KTTA|2 years of annual SEC 10-K data (FY2021-FY2022)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 2 fiscal years. All figures from audited SEC 10-K filings.
Pasithea Therapeutics Corp. had $45M in total assets and $51M in shareholders' equity as of FY2022.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2022 | FY2021 |
|---|---|---|
| Cash & Equivalents | $33.1M | $53.0M |
| Current Assets | $34.1M | $53.3M |
| PP&E (Net) | $378.8K | $20.1K |
| Goodwill | $1.3M | - |
| Total Assets | $45.2M | $53.3M |
| Current Liabilities | $1.9M | $447.3K |
| Shareholders' Equity | $51.4M | $241.4K |